India Exchange Filings

38 BlackBio Dx Q2 FY27 Earnings and Board Meeting Highlights

3B BlackBio Dx Ltd approves Q2 FY27 results, reporting consolidated revenue of ₹48.28 crore

  • Revenue rose 42.4% year on year and 44.2% sequentially; net profit was ₹18.02 crore, up 19.8% year on year and 100.7% sequentially.
  • Calculated operating margin was 40.7%; no exceptional items were reported.
  • Auditors’ limited review found no material misstatement; subsidiary interim results were not independently reviewed by their auditors.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.